Suvaporn Anugulruengkitt
Overview
Explore the profile of Suvaporn Anugulruengkitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puthanakit T, Chokephaibulkit K, Anugulruengkitt S, Chaithongwongwatthana S, Phongsamart W, Wittawatmongkol O, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S56-S60.
PMID: 39951076
Background: Vaccination in pregnancy with recombinant pertussis vaccine results in similar or higher antibody levels in infants compared with chemically detoxified acellular pertussis vaccine (Tdapchem). We evaluated antibody responses to...
2.
Wacharachaisurapol N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, Songtaweesin W, Tawon Y, et al.
Pediatr Infect Dis J
. 2025 Jan;
PMID: 39836566
We investigated the steady-state pharmacokinetics of generic abacavir (ABC)/lamivudine (3TC) dispersible tablets (DTs) in young children living with HIV aged 3 months to <7 years, weighing 6 to <20 kg....
3.
Charoenwong K, Wacharachaisurapol N, Sukkummee W, Sophonphan J, Suchartlikitwong P, Chatsuwan T, et al.
Pediatr Infect Dis J
. 2024 Dec;
44(3):207-213.
PMID: 39724654
Background: Rates of carbapenem-resistant Acinetobacter baumannii are rising in Thailand. Although high-dose (HD) sulbactam is recommended for treating carbapenem-resistant A. baumannii infections, data on plasma sulbactam concentrations in children are...
4.
Puthanakit T, Tangsathapornpong A, Anugulruengkitt S, Nantanee R, Bunjoungmanee P, Mansouri S, et al.
Lancet Child Adolesc Health
. 2024 Nov;
8(12):900-909.
PMID: 39572123
Background: A resurgence of pertussis has increased the demand for low-cost vaccines. The aim of this study was to test the immunogenicity of a booster acellular monovalent pertussis vaccine containing...
5.
Chantasrisawad N, Boonyasuppayakorn S, Anugulruengkitt S, Puthanakit T
Pediatr Infect Dis J
. 2024 Sep;
44(2):e60-e62.
PMID: 39230282
Chikungunya virus (CHIKV), transmitted by Aedes mosquitoes, has reemerged in Southeast Asia since 2019. A retrospective review of CHIKV cases was conducted. Children commonly presented with high-grade fever, rash, arthralgia,...
6.
Rungsapphaiboon A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, Phasomsap C, Tawan M, et al.
Pediatr Infect Dis J
. 2024 Jul;
43(8):789-794.
PMID: 39018516
Introduction: Dolutegravir (DTG) dispersible tablet (DTG-DT) is a pediatric-friendly formulation. We aimed to describe the pharmacokinetics and virologic responses of generic DTG-DT in children weighing <20 kg. Methods: Children living...
7.
Moolasart V, Srijareonvijit C, Charoenpong L, Kongdejsakda W, Anugulruengkitt S, Kulthanmanusorn A, et al.
Children (Basel)
. 2024 Jun;
11(6).
PMID: 38929317
Background: Healthcare-associated infections (HAIs) pose a grave threat to patient safety, morbidity, and mortality, contributing to antimicrobial resistance. Thus, we estimated the point prevalence, risk factors, types, and pathogens of...
8.
Chokephaibulkit K, Puthanakit T, Chaithongwongwatthana S, Bhat N, Tang Y, Anugulruengkitt S, et al.
Vaccine
. 2023 Dec;
42(2):383-395.
PMID: 38061956
Introduction: Recombinant acellular pertussis (ap) vaccines containing genetically inactivated pertussis toxin (PT) and filamentous hemagglutinin (FHA) with or without tetanus (TT) and diphtheria (DT) vaccines (Td) were found safe and...
9.
Nantanee R, Jaru-Ampornpan P, Chantasrisawad N, Himananto O, Papakhee S, Sophonphan J, et al.
Vaccine X
. 2023 Aug;
15:100367.
PMID: 37601322
Background: Children 6 months to < 5 years old are recommended to receive 3-dose regimen of BNT162b2. Children previously infected with Omicron variant of SARS-CoV-2 develop immunity from natural infection,...
10.
Phongsamart W, Allen K, Vandepitte W, Techasaensiri C, Kosalaraksa P, Laoprasopwattana K, et al.
IJID Reg
. 2023 Jul;
8:49-57.
PMID: 37415954
Objective: To describe the risk condition status and clinical outcomes among Thai children hospitalized with pneumococcal disease. Methods: In this retrospective analysis, children with invasive pneumococcal disease (IPD) or x-ray-confirmed...